logo

For the Inventor, By the Inventor

Reinach, Switzerland

Evolva Sa


USPTO Granted Patents = 69

% Expired Patents = 17.4



Trademarks = 6

Forward Citations = 417

Loading Chart...
Loading Chart...

142 inventors (with patents filed for the assignee):

goldMedal Jorgen Hansen (18 out of 21 patents)

silverMedal Jens Houghton-Larsen (15 out of 17 patents)

bronzeMedal Veronique Douchin (14 out of 15 patents)

4.  Michael Dalgaard Mikkelsen (14 out of 16 patents)

5.  Simon Carlsen (12 out of 13 patents)

6.  Kim Olsson (11 out of 11 patents)

7.  Ernesto Simon (11 out of 11 patents)

8.  Yaoquan Liu (9 out of 21 patents)

9.  Nina Nicoline Rasmussen (8 out of 9 patents)

10.  Michael Naesby (8 out of 9 patents)

11.  Louis Düring (7 out of 7 patents)

12.  Michael Katz (7 out of 9 patents)

13.  Angelika Semmler (6 out of 6 patents)

14.  Sathish Kumar (6 out of 7 patents)

15.  Muthuswamy Panchapagesa Murali (6 out of 6 patents)


Core Competencies:
Nootkatone
Steviol Glycosides
Mogroside Compounds
Terpenes
Biosynthesis
Recombinant Hosts
Microbial Fermentation
Enzymatic Synthesis
Phenylpropanoids
Resveratrol
Pinosylvin
Clavine-Type Alkaloids

69 patents:

1. 12709769 - METHODS FOR IMPROVED PRODUCTION OF REBAUDIOSIDE D AND REBAUDIOSIDE M (2026-08-18),
2. 11896008 - Use of nootkatone to treat mosquito infestations (2024-02-13),
3. 11821015 - Production of steviol glycosides in recombinant hosts (2023-11-21),
4. 11807888 - Production of steviol glycoside in recombinant hosts (2023-11-07),
5. 11800867 - Methods of repelling biting arthropods, reducing pathogen spread and treating arthropod infestation (2023-10-31),
6. 11737459 - Use of nootkatone to kill sap-sucking insects (2023-08-29),
7. 11530431 - Methods for improved production of Rebaudioside D and Rebaudioside M (2022-12-20),
8. 11466302 - Production of steviol glycosides in recombinant hosts (2022-10-11),
9. 11396669 - Production of steviol glycosides in recombinant hosts (2022-07-26),
10. 11248248 - Production of mogroside compounds in recombinant hosts (2022-02-15),
11. 11191266 - Methods and compositions for the treatment of infections and arthropod infestation (2021-12-07),
12. 11168343 - Production of steviol glycosides in recombinant hosts (2021-11-09),
13. 11155841 - Method for producing sphingoid base or sphingolipid (2021-10-26),
14. 11154057 - Use of nootkatone to treat mosquito infestations (2021-10-26),
15. 11136283 - Recovering and purifying resveratrol produced by microbial fermentation (2021-10-05),
Evolva is a biotechnology company that focuses on developing and commercializing sustainable ingredients for various industries. They use advanced biotechnology to create high-value ingredients, including flavors, fragrances, and cosmetic ingredients, with a focus on sustainability and environmental impact reduction. Evolva partners with industry leaders, leveraging their technology platform to improve existing products or create new ingredients with better performance and sustainability. Through their innovative solutions, Evolva aims to contribute towards a more sustainable and healthier future.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

69 Patents

#5 in Reinach

#226 in Switzerland

#10,745 in the World

Reinach, CH
Reinach, Switzerland

Evolva Sa

Forward Citations = 417

142 inventors:

goldMedal Jorgen Hansen (18 out of 21 patents)

silverMedal Jens Houghton-Larsen (15 out of 17 patents)

bronzeMedal Veronique Douchin (14 out of 15 patents)

4.  Michael Dalgaard Mikkelsen (14 out of 16 patents)

5.  Simon Carlsen (12 out of 13 patents)

Please report any incorrect information to [email protected]
Loading…